1084057

Abbvie Biotechnology Ltd. — FEI 3004620772

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 25, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Barceloneta, PR (United States)

Citations

IDCFRDescription
202721 CFR 211.192Investigations of discrepancies, failures
358521 CFR 211.110(a)Control procedures to monitor and validate performance
438221 CFR 211.198(b)(2)Written record of complaint to include findings, follow-up